SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031582
Filing Date
2024-08-13
Accepted
2024-08-13 15:57:36
Documents
70
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1267336
2 ex31-1.htm EX-31.1 18344
3 ex32-1.htm EX-32.1 6991
4 logo_001.jpg GRAPHIC 8575
  Complete submission text file 0001493152-24-031582.txt   6228176

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hepa-20240630.xsd EX-101.SCH 35347
6 XBRL CALCULATION FILE hepa-20240630_cal.xml EX-101.CAL 49121
7 XBRL DEFINITION FILE hepa-20240630_def.xml EX-101.DEF 203945
8 XBRL LABEL FILE hepa-20240630_lab.xml EX-101.LAB 363664
9 XBRL PRESENTATION FILE hepa-20240630_pre.xml EX-101.PRE 319699
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1020290
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 241201151
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)